In silico characterisation of C11orf42 as a potential therapeutic target in triple-negative breast cancer. - Mohammed Alfaifi; Hossam Kamli (Comput. Biol. Chem., 2026)

Biomarker discovery and drug repurposing in hepatocellular carcinoma through transcriptomics, machine learning, network pharmacology, and molecular dynamics. - Mohammed Alfaifi; Hossam Kamli; Najeeb Ullah Khan; Ahsanullah Unar (Comput. Biol. Chem., 2026)